200 related articles for article (PubMed ID: 38009863)
1. Role of neutrophils in cutaneous lupus erythematosus.
Yamamoto T
J Dermatol; 2024 Feb; 51(2):180-184. PubMed ID: 38009863
[TBL] [Abstract][Full Text] [Related]
2. Investigating the presence of neutrophil extracellular traps in cutaneous lesions of different subtypes of lupus erythematosus.
Safi R; Al-Hage J; Abbas O; Kibbi AG; Nassar D
Exp Dermatol; 2019 Nov; 28(11):1348-1352. PubMed ID: 31529548
[TBL] [Abstract][Full Text] [Related]
3. The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus.
Cho YM; Furie R
Immunotherapy; 2024 Jan; 16(1):15-20. PubMed ID: 37877249
[TBL] [Abstract][Full Text] [Related]
4. B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity.
Abernathy-Close L; Lazar S; Stannard J; Tsoi LC; Eddy S; Rizvi SM; Yee CM; Myers EM; Namas R; Lowe L; Reed TJ; Wen F; Gudjonsson JE; Kahlenberg JM; Berthier CC
Front Immunol; 2021; 12():775353. PubMed ID: 34868043
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in cutaneous lupus.
Maz MP; Martens JWS; Hannoudi A; Reddy AL; Hile GA; Kahlenberg JM
J Autoimmun; 2022 Oct; 132():102865. PubMed ID: 35858957
[TBL] [Abstract][Full Text] [Related]
6. Plasmacytoid Dendritic Cells Are Not Major Producers of Type 1 IFN in Cutaneous Lupus: An In-Depth Immunoprofile of Subacute and Discoid Lupus.
Vazquez T; Patel J; Kodali N; Diaz D; Bashir MM; Chin F; Keyes E; Sharma M; Sprow G; Grinnell M; Dan J; Werth VP
J Invest Dermatol; 2024 Jun; 144(6):1262-1272.e7. PubMed ID: 38086428
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous and systemic connections in lupus.
Maz MP; Michelle Kahlenberg J
Curr Opin Rheumatol; 2020 Nov; 32(6):583-589. PubMed ID: 32826479
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.
Niebel D; de Vos L; Fetter T; Brägelmann C; Wenzel J
Am J Clin Dermatol; 2023 Jul; 24(4):521-540. PubMed ID: 37140884
[TBL] [Abstract][Full Text] [Related]
9. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Immune Cells as a Therapy for Cutaneous Lupus Erythematosus.
Soto JA; Melo-González F; Riedel CA; Bueno SM; Kalergis AM
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142624
[TBL] [Abstract][Full Text] [Related]
11. Immunogenetics of cutaneous lupus erythematosus.
Hersh AO; Arkin LM; Prahalad S
Curr Opin Pediatr; 2016 Aug; 28(4):470-5. PubMed ID: 27386968
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of cutaneous lupus erythema associated with and without systemic lupus erythema.
Zhang YP; Wu J; Han YF; Shi ZR; Wang L
Autoimmun Rev; 2017 Jul; 16(7):735-742. PubMed ID: 28483542
[TBL] [Abstract][Full Text] [Related]
13. Emerging immunotherapeutic strategies for cutaneous lupus erythematosus: an overview of recent phase 2 and 3 clinical trials.
Lim D; Kleitsch J; Werth VP
Expert Opin Emerg Drugs; 2023 Dec; 28(4):257-273. PubMed ID: 37860982
[TBL] [Abstract][Full Text] [Related]
14. Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus.
Gu HJ; Song S; Roh JY; Jung Y; Kim HJ
Lupus; 2021 Aug; 30(9):1427-1437. PubMed ID: 34013817
[TBL] [Abstract][Full Text] [Related]
15. The pathogenesis of cutaneous lupus erythematosus: The aberrant distribution and function of different cell types in skin lesions.
Zhou X; Yan J; Lu Q; Zhou H; Fan L
Scand J Immunol; 2021 Jan; 93(1):e12933. PubMed ID: 32654170
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
17. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa.
Sarkar MK; Hile GA; Tsoi LC; Xing X; Liu J; Liang Y; Berthier CC; Swindell WR; Patrick MT; Shao S; Tsou PS; Uppala R; Beamer MA; Srivastava A; Bielas SL; Harms PW; Getsios S; Elder JT; Voorhees JJ; Gudjonsson JE; Kahlenberg JM
Ann Rheum Dis; 2018 Nov; 77(11):1653-1664. PubMed ID: 30021804
[TBL] [Abstract][Full Text] [Related]
18. An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice.
Patel J; Borucki R; Werth VP
Curr Rheumatol Rep; 2020 Aug; 22(10):69. PubMed ID: 32845411
[TBL] [Abstract][Full Text] [Related]
19. Immunologic and genetic considerations of cutaneous lupus erythematosus: a comprehensive review.
Yu C; Chang C; Zhang J
J Autoimmun; 2013 Mar; 41():34-45. PubMed ID: 23380467
[TBL] [Abstract][Full Text] [Related]
20. The DNA sensors AIM2 and IFI16 are SLE autoantigens that bind neutrophil extracellular traps.
Antiochos B; Trejo-Zambrano D; Fenaroli P; Rosenberg A; Baer A; Garg A; Sohn J; Li J; Petri M; Goldman DW; Mecoli C; Casciola-Rosen L; Rosen A
Elife; 2022 May; 11():. PubMed ID: 35608258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
